News › Clinical Practice, Industry News, Patient Care

Clinical Study Demonstrates Improvement in Injection Recovery with Topical Use of Alastin’s INhance

June 11, 2020

Alastin Skincare, Inc.—a specialty aesthetics company dedicated to developing and marketing clinically tested, physician-dispensed skin care products, has announced the publication of a clinical study highlighting its most recent product, INhance post-injection serum with TriHex Technology. The Journal of Drugs in Dermatology (JDD)—the peer-reviewed publication authored by Alan D. Widgerow, MBBCh, MMed (Plast), FCS, Carolyn Jacob, MD, and Melanie D. Palm, MD, MBA—reviews the science behind the product and demonstrates the clinical utility of combining a topical adjunct with injectable procedures.
Read more at PR Newswire >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • Longevity, Safety, and Innovation: Merz Aesthetics on Natural Results and the Future of Regenerative Aesthetics
    • Galderma Celebrates 30 Years of Restylane
    • FDA Issues Letter to Evolus Over Jeuveau Social Media Promotion
    • North Becomes Platinum Vendor Affiliate with the American Med Spa Association
    • Retatrutide Phase 3 Trial: Adults With Type 2 Diabetes Lost Average of 50 Pounds
Advertisement